The DOI matches its Crossref record; 464 of the 464 references it cites were found in a registry or an index.
Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus
Abstract
BACKGROUND: Metformin is an oral anti-hyperglycemic agent that has been shown to reduce total mortality compared to other anti-hyperglycemic agents, in the treatment of type 2 diabetes mellitus. Metformin, however, is thought to increase the risk of lactic acidosis, and has been considered to be contraindicated in many chronic hypoxemic conditions that may be associated with lactic acidosis, such as cardiovascular, renal, hepatic and pulmonary disease, and advancing age. OBJECTIVES: To assess the incidence of fatal and nonfatal lactic acidosis, and to evaluate blood lactate levels, for those on metformin treatment compared to placebo or non-metformin therapies. SEARCH STRATEGY: A comprehensive search was performed of electronic databases to identify studies of metformin treatment. The search was augmented by scanning references of identified articles, and by contacting principal investigators. SELECTION CRITERIA: Prospective trials and observational cohort studies in patients with type 2 diabetes of least one month duration were included if they evaluated metformin, alone or in combination with other treatments, compared to placebo or any other glucose-lowering therapy. DATA COLLECTION AND ANALYSIS: The incidence of fatal and nonfatal lactic acidosis was recorded as cases per patient-years, for metformin treatment and for non-metformin treatments. The upper limit for the true incidence of cases was calculated using Poisson statistics. In a second analysis lactate levels were measured as a net change from baseline or as mean treatment values (basal and stimulated by food or exercise) for treatment and comparison groups. The pooled results were recorded as a weighted mean difference (WMD) in mmol/L, using the fixed-effect model for continuous data. MAIN RESULTS: Pooled data from 347 comparative trials and cohort studies revealed no cases of fatal or nonfatal lactic acidosis in 70,490 patient-years of metformin use or in 55,451 patients-years in the non-metformin group. Using Poisson statistics the upper limit for the true incidence of lactic acidosis per 100,000 patient-years was 4.3 cases in the metformin group and 5.4 cases in the non-metformin group. There was no difference in lactate levels, either as mean treatment levels or as a net change from baseline, for metformin compared to non-metformin therapies. AUTHORS' CONCLUSIONS: There is no evidence from prospective comparative trials or from observational cohort studies that metformin is associated with an increased risk of lactic acidosis, or with increased levels of lactate, compared to other anti-hyperglycemic treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 401–464 of 464
Rs, E. (1991) · PubMed · Cited by 15
Influence of metformin on arginine-induced glucagon secretion in human diabetes.
Jl, C., As, L., & Lefèbvre, P. J. (1975) · PubMed · Cited by 15
Nateglinide combination therapy with basal insulin and metformin in patients with Type 2 diabetes
Juurinen, L., Tiikkainen, M., Saltevo, J. T., Nikkilä, K., Lanki, H., Leppävuori, E., Kock, T., Teikari‐Myyrä, T., Kauppinen‐Mäkelin, R., Kotronen, A., et al. (2009) · Diabetic Medicine · doi:10.1111/j.1464-5491.2009.02691.x · Cited by 14
Raskin, P., Lewin, A., Reinhardt, R., Lyness, W. H., & for the Repaglinide/Metformin Fixed‐Dose Combination Study Group (2009) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2009.01062.x · Cited by 14
Panikar, V., Joshi, S., Bukkawar, A., Nasikkar, N., & Santvana, C. (2007) · PubMed · Cited by 14
Metformin and clofibrate in maturity onset diabetes mellitus: advantages of combined treatment.
Silva, S. R. D., Betteridge, D. J., Shawe, J. E., Cudworth, A. G., & Alberti, K. G. M. M. (1979) · PubMed · Cited by 14
Schiel, R., & Müller, U. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-985367 · Cited by 14
BRUCE, S., Park, J.-S., Fiedorek, F. T., & Howlett, H. C. S. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.00994.x · Cited by 13
Yegnanarayan, R., Suryavanshi, M., Singh, M., & Desai, S. (2008) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.09.001 · Cited by 13
Monami, M., Marchionni, N., Masotti, G., & Mannucci, E. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.03.135 · Cited by 13
Zapecka-Dubno, B., Czyiyk, A., Dworak, A., & Bak, M. I. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300423 · Cited by 13
Lunetta, M., & Mauro, M. D. (1996) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(96)01277-6 · Cited by 13
Chalmers, J., Hunter, J. E., Robertson, S., Baird, J., Martin, M., Franks, C. I., Whately‐Smith, C., Mariz, S., & Campbell, I. W. (2007) · Current Medical Research and Opinion · doi:10.1185/030079907x210606 · Cited by 13
Peacock, I., Hawkins, M., & Heptinstall, S. (1986) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1661564 · Cited by 13
Combined trial of acetohexamide and two diguanide preparations
Szanto, S. (1964) · Irish Journal of Medical Science (1971 -) · doi:10.1007/bf02953855 · Cited by 12
Metformin and lipoprotein(a) levels.
Kiayias, J. A., Vlachou, E. D., & Lakka-Papadodima, E. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.859b · Cited by 12
Impact of Prandial Plus Basal vs Basal Insulin on Glycemic Variability in Type 2 Diabetic Patients
Hirsch, I. B., Yuan, H., Campaigne, B. N., & Tan, M. H. (2009) · Endocrine Practice · doi:10.4158/ep08308.orr · Cited by 12
Safety and efficacy of metformin in a restricted formulary.
Swislocki, A., Khuu, Q., Liao, E., Wu, E., Beza, F., Lopez, J., Kwan, G., & Noth, R. H. (1999) · PubMed · Cited by 11
Raptis, A. E., Tountas, N. A., Yalouris, A., Halvatsiotis, P., & Raptis, S. A. (1996) · Hormone and Metabolic Research · doi:10.1055/s-2007-979135 · Cited by 11
Roger, P., Auclair, J., & Drain, P. (1999) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(98)00004-x · Cited by 11
Pioglitazone Metabolic Effect in Metformin-Intolerant Obese Patients Treated with Sibutramine
Derosa, G., Mereu, R., SALVADEO, S. A. T., D’Angelo, A., Ciccarelli, L., Piccinni, M. N., Ferrari, I., Gravina, A., Maffioli, P., & Cicero, A. F. G. (2009) · Internal Medicine · doi:10.2169/internalmedicine.48.1670 · Cited by 11
Niazi, R., & Muzaffar, Z. (1998) · PubMed · Cited by 11
Aguilar, C. A., Wong, B., Gomez-Perez, F. J., & Rull, J. A. (1992) · PubMed · Cited by 10
Irsigler, K., Kritz, H., Regal, H., & Foltin, E. (1978) · PubMed · Cited by 10
Bhansali, A. K., & Masoodi, S. R. (2005) · PubMed · Cited by 9
[Gliclazide and metformin combination in patients with type 2 diabetes. Preliminary data].
Galeone, F., Fiore, G., Arcangeli, A., & Mannucci, E. (1998) · PubMed · Cited by 9
METFORMIN COMBINED WITH CHLORPROPAMIDE IN THE TREATMENT OF DIABETES MELLITUS.
Bingle, J. P., & JAMES, J. L. (1964) · PubMed · Cited by 9
[The combination of insulin and metformin in obese patients with type-2 diabetes mellitus].
Izquierdo, M. I. S.-B., Rueda, J. M. I., & Pérez, R. R. D. A. (1999) · PubMed · Cited by 8
Effect of metformin on glycaemic control in type 2 diabetes in daily practice: a retrospective study
Stades, A. M. E. (2000) · The Netherlands Journal of Medicine · doi:10.1016/s0300-2977(99)00128-x · Cited by 8
[Effect of biguanide therapy on lactate metabolism during graded submaximal ergometric testing].
Pilger, E., Schmid, P., & Goebel, R. (1978) · PubMed · Cited by 8
Gregorio, F., Ambrosi, F., Angelici, F., Cristallini, S., Fl, D., Vespasiani, G., Santeusanio, F., & Filipponi, P. (1989) · PubMed · Cited by 8
González-Ortíz, M., & Martínez‐Abundis, E. (2004) · PubMed · Cited by 7
Tomioka, S., Ogata, H., Tamura, Y., Shimizu, T., Watada, H., Fujitani, Y., Kawamori, R., & Hirose, T. (2007) · Endocrine Journal · doi:10.1507/endocrj.k06-162 · Cited by 7
D'Argenzio, R., Cavallo, P., Merante, D., & Morelli, A. M. (1996) · PubMed · Cited by 7
Velussi, M., Cernigoi, A. M., Viezzoli, L., & Caffau, C. (1992) · PubMed · Cited by 7
Vuković, M., Lapčević, M., Kalezic, N. K., & Gvozdenović, B. (2007) · Srpski arhiv za celokupno lekarstvo · doi:10.2298/sarh0708447v · Cited by 6
Runge, S., Alte, D., Baumeister, S., & Völzke, H. (2008) · Hormone and Metabolic Research · doi:10.1055/s-2008-1065319 · Cited by 6
[Treatment of obese diabetic patients using glucophage retard].
Munk, W. (1975) · PubMed · Cited by 6
[EXPERIENCE WITH THE BIGUANIDE "GLUCOPHAGE"].
Puchegger, R. (1964) · PubMed · Cited by 6
Metformin as secondary therapy in a defined population with type 2 diabetes
Brown, J. B., & Pedula, K. L. (1999) · Clinical Therapeutics · doi:10.1016/s0149-2918(99)80047-2 · Cited by 5
Signore, A., Fiore, V., Chianelli, M., Procaccini, E., Barone, R., Ronga, G., Negri, M., & Pozzilli, P. (1996) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(96)01280-6 · Cited by 5
[Dimethylbiguanide in the treatment of diabetes mellitus].
Allen, G. E., Montgomery, D. A. D., & Ja, W. (1961) · PubMed · Cited by 5
Viveros, M. G., Prado Vega, R., Rull, J. A., & Lozano-Castaneda, O. (1971) · PubMed · Cited by 5
Utility of metformin as a non-hormonal agent in the treatment of diabetes mellitus.
Bj, M., Bj, V., Dv, N., & Pr, V. (1963) · PubMed · Cited by 5
Laurenti, O., Bravi, M. C., Cassone-Faldetta, M., & Mattia, G. D. (1992) · PubMed · Cited by 5
Dimethyldiguanide in diabetes mellitus; report of a small trial.
Donnelly, P. E. (1960) · PubMed · Cited by 5
Schulte, J., Viveros, M. G., Rull, J. A., & Lozano-Castaneda, O. (1973) · PubMed · Cited by 5
[Therapy of diabetes mellitus using metformin. Clinical study on 60 patients].
Klein, W., & Herrmann, A. (1975) · PubMed · Cited by 5
[Results in the treatment of diabetes with glucophage retard].
Beyer, G. (1975) · PubMed · Cited by 5
Dies, H., Lozano-Castaneda, O., Viveros, M. G., Schulte, J., Figueroa, J., & Rull, J. A. (1978) · PubMed · Cited by 5
[Clinical trial with DMBG (Melbin) in diabetes mellitus].
SUGAWARA, Y., Niimi, T., Sato, T., NAKAI, Y., MIYATA, K., KANO, H., Kato, T., & KOMATSUBARA, K. (1962) · PubMed · Cited by 4
Rodríguez, Á., Reviriego, J., Polavieja, P., & Mesa, J. (2008) · Medicina Clínica · doi:10.1016/s0025-7753(08)75486-1 · Cited by 4
[Treatment of 81 cases of diabetes mellitus with N,N,dimethyl-biguanide].
Messens, Y., & Margouliès, M. (1965) · PubMed · Cited by 4
Jm, R. L. (1969) · PubMed · Cited by 4
Giugliano, D., Torella, R., Improta, L., & Scognamiglio, G. (1979) · PubMed · Cited by 4
Buturović, B. A. –., & Kacila, M. (2008) · Biomolecules and Biomedicine · doi:10.17305/bjbms.2008.2882 · Cited by 4
[Glycemic equilibrium and weight evolution in diabetics taking metformin].
Isnard, F., & André, P. (1991) · PubMed · Cited by 4
[Tolbutamide-dimethyl-biguanide association in the treatment of diabetes mellitus].
Bernard, C., & Bernard, R. (1965) · PubMed · Cited by 4
Bruneder, H., & Klein, H. J. (1978) · PubMed · Cited by 4
The effect of metformin on individual amino acid absorption.
Ismail, A. A., Badrawi, H. M., Nasr, S., Khater, R., Hafez, A. A., El‐Kirdassy, Z. H. M., & Ms, M. (1978) · PubMed · Cited by 4
[Treatment of diabetes with N,N-dime-thylbiguanide].
Muntoni, S. (1962) · PubMed · Cited by 4
[Treatment of diabetes by NN-dimethyl biguanide].
Azérad, E., & Lasry, M. (1960) · PubMed · Cited by 4
Metformin plus Roziglitazone versus Metformin for Type 2 Diabetes:A Systematic review
Cheng, W. (2009) · Zhongguo xunzheng yixue zazhi · Cited by 3
(1990) · PubMed
Research works printed but not linked: 44
- Abbink, 2000, Vascular effects of glibenclamide, glimepiride, metformin and acarbose in Type 2 DM patients, Diabetologia, 43, A39
- Andras, 1962, [Experience with biguanide treatment for diabetes mellitus], Orvosi hetilap, 103, 1029
- Bacci, 1961, [N.N. dimethyl-biguanide (DMGG) in the treatment of Diabetes meliitus], Minerva Medica, 52, 2770
- Boronat, 2000, [Effectiveness of treatment with metformin in patients with type 2 diabetes mellitus poorly controlled with insulin treatment], Revista Clinica Espanola, 200, 74
- Botha, 1977, Association of lactic acidosis with biguanide therapy [letter], South African Medical Journal, 52, 301
- Campbell, 1988, Effects of metformin on blood pressure and microalbuminuria in diabetes mellitus, Diabete & Metabolisme, 14, 613
- Canivet, 1962, [The treatment of Diabetes mellitus: Statistical results after a review of 1190 cases], La Presse Medicale, 70, 2038
- Davidson, 2000, Effect of metformin/glyburide tablets on HBA1c in first-line treatment of Type 2 Diabetes, Diabetologia, 43, A184
- DeFronzo, 1993, Combined metformin/glyburide treatment in NIDDM patients not optimally responding to maximum dose sulfonyluria: Results of a multicenter trial., Diabetes, 42, 146A (abs 455)
- 1993, Efficacy and safety of metformin in NIDDM: Results of a muticenter trial, Diabetes, 42, Abs 178
- Dornan, 1988, Metformin monotherapy for obese non-insulin-dependent diabetes. A double-blind evaluation, Diabetic Medicine, 5, 5 (Abs A17)
- Eriksson, 2007, Short-term effects of metformin in type 2 diabetes, Diabetes, Obesity & Metabolism, 9, 483, 10.1111/j.1463-1326.2006.00624.x · DOI
- Ferner, 1988, Impaired beta-cell responses improve when fasting blood glucose concentration is reduced in non-insulin-dependent diabetes, Quarterly Journal of Medicine, 66, 137
- Gursoy, 2000, The effect of metformin on insulin resistance and serum lipid profiles, Diabetologia, 43, A150
- Herman, 1961, Dimethyldiguanide (Glucophage, LA 6023) in Diabetes mellitus, South African Medical Journal, 35, 286
- Hu, 2008, [Effect of insulin plus rosiglitazone or metformin on serum N-terminal pro-brain natriuretic peptide in type 2 diabetes mellitus: a randomized-controlled study]. [Chinese], Shengwu Yixue Gongchengxue Zazhi/Journal of Biomedical Engineering, 25, 682
- Jackson, 1962, Combined oral therapy in Diabetes, South African Medical Journal, 36, 727
- Jones, 2000, Long-term efficacy of rosiglitazone as monotherapy or in combination with metformin, Diabetologia, 43, A192
- Jones, 2000, Addition of rosiglitazone to metformin is effective in obese, insulin-resistant patients with Type 2 Diabetes, Diabetologia, 43, A191
- Kooy, 2009, Increase in value of adding metformin to insulin therapy in type 2 diabetes: More favorable weight with less macrovascular complications, Nederlands Tijdschrift voor Geneeskunde, 153, 1005
- Marena, 1994, Metabolic effects of metformin addition to chronic glibenclamide treatment in type 2 diabetes [see comments], Diabete & Metabolisme, 20, 15
- Mughal, 2000, The effect of metformin on glycemic control, serum lipids and lipoproteins in diet alone and sulfonylurea-treated type 2 diabtic patients with sub-optimal metabolic control, Journal of the Pakistani Medical Association, 50, 381
- Pirart, 1961, [A new oral antidiabetic medicine: N.N. Dimethylbiguanide. Clinical trial alternating a placebo with a sulfamide], Acta Clinica Belgica, 16, 575
- Siedradzki, 1999, [Assessment of efficacy and safety of acarbose in the treatment of diabetes mellitus. Observation study in the conditions of general health care], Przeglad Lekarski, 56, 335
- Sterne, 1963, [Report on five years experience with Metformin], Wiener Medizinische Wochenschrift, 113, 599
- Stratmann, 1965, [Experience with Dimethylbiguanide in late failrues of oral diabetes therapy], Medizinische Welt, 49, 2743
- Wulffele, 2000, Metformin and insulin therapy decreases glycosylated hemoglobin and insulin requirement in Type 2 Diabetes, Diabetologia, 43, A184
- Debry, 1964, [Study of lactic acid levels on an empty stomach in diabetic patients treated with N-N-dimethylbiguanide], Diabete, 12, 239
- Debry, 1966, [Results of the treatment of Diabetes mellitus in the adult with the association of Metformin and sulfamides (concerning 197 cases)], Journal de Medicine de Lyon, 47, 407
- Debry, 1966, [Results of the treatment of Diabetes mellitus in the adult with metformin (concerning 202 cases0], Journal de Medicine de Lyon, 47, 395
- Isnard, 1996, [Long term treatment with biguanides in the natural evolution of non-insulin-dependent diabetes], Journ Annu Diabetol Hotel Dieu, 273
- Javaid, 2007, A comparative study of the effects of hypogycemic agents on serum electrolutes in the diabetic patients, Pakistani Journal of Pharmacological Science, 20, 67
- Lalau, 1994, Metformin-associated lactic acidosis in diabetic patients with acute renal failure. A critical analysis of its pathogenesis and prognosis, Nephrology Dialysis and Transplantation, 9, 126
- Lapina, 2008, [Efficacy and safety of the use of metformin in patients with chronic heart failure and type 2 diabetes mellitus. results of the study "rational effective mulicomponent therapy in the battle against diabetes mellitus in patients with chronic heart failure"]. [Russian], Kardiologiia, 48, 58
- Messens, 1966, [Treatment of diabetes mellitus with N.N. dimethy-biguanide], Diabete, 14, 74
- Muntoni, 1965, [Dimethyl-biguanide in the treatment of diabetes mellitus], La Clinica terapeutica, 35, 227
- O'Connor, 1998, Care of adults with type 2 diabetes mellitus. A review of the evidence [see comments], Journal of Family Practice, 47, S13
- Orlikowska, 1966, [Influence of N.N. dimethyl biguandie on certain elements of lipid metabolism in diabetic patients], Le Diabete, 14, 183
- Rambert, 1961, [Treatment of diabetes mellitus with NN-dimethyl-diguanide. Experience of 177 cases], Semaine des Hospitaux de Paris, 37, 247
- Sharabashi, 2006, Retrospecitve review of metformin in inpatients and outpatients at the University of Michigan, Diabetes Care, 29, 170, 10.2337/diacare.29.01.06.dc05-1762 · doi:10.2337/diacare.29.01.06.dc05-1762
- Teitelbaum, 1963, [Biguanides and sulfamides in small doses in the initial treatment of diabetes in obese patients], Diabete, 11, 342
- 1999, Metformin hydrochloride, 2755
- Olivia, 1970, Lactic acidosis, American Journal of Medicine, 48, 208
- Sterne, 1959, [Treatment of Diabetes mellitus with N.N. Dimethyl Guanil Guanidine (LA 6023, glucophage)], Therapie, 14, 625
Cited by
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2015) · Diabetes Care · doi:10.2337/dc14-2441 · Cited by 3,066
Chatterjee, S., Khunti, K., & Davies, M. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30058-2 · Cited by 2,577
Inker, L. A., Astor, B. C., Fox, C. H., Isakova, T., Lash, J. P., Peralta, C. A., Kurella Tamura, M., & Feldman, H. I. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.01.416 · Cited by 1,779
KDIGO 2020 Clinical practice guideline for diabetes management in chronic kidney disease
de Boer, I. H., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.06.019 · Cited by 1,399
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
Rossing, P., Caramori, M. L., Chan, J. C. N., Heerspink, H. J. L., Hurst, C., Khunti, K., Liew, A., Michos, E. D., Navaneethan, S. D., Olowu, W. A., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.008 · Cited by 1,373
Metadata
- Authors
- Salpeter, S. R., Greyber, E., Pasternak, G. A., & Salpeter (posthumous), E. E.
- Venue
- Cochrane Database of Systematic Reviews
- Publisher
- John Wiley & Sons, Ltd
- Published
- 2010-01-20
- Issue
- 1
- Pages
- CD002967-CD002967
- ISSN
- 1361-6137 (ISSN-L)
- OpenAlex
- W4233394038
- Cited by
- 434
- References
- 464
- Type
- reference entry
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.